173 related articles for article (PubMed ID: 33607310)
1. A Validation Study of the Recommended Change in Residual Tumor Descriptors Proposed by the International Association for the Study of Lung Cancer for Patients With pN2 NSCLC.
Yun JK; Lee GD; Choi S; Kim YH; Kim DK; Park SI; Kim HR
J Thorac Oncol; 2021 May; 16(5):817-826. PubMed ID: 33607310
[TBL] [Abstract][Full Text] [Related]
2. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer.
Edwards JG; Chansky K; Van Schil P; Nicholson AG; Boubia S; Brambilla E; Donington J; Galateau-Sallé F; Hoffmann H; Infante M; Marino M; Marom EM; Nakajima J; Ostrowski M; Travis WD; Tsao MS; Yatabe Y; Giroux DJ; Shemanski L; Crowley J; Krasnik M; Asamura H; Rami-Porta R;
J Thorac Oncol; 2020 Mar; 15(3):344-359. PubMed ID: 31731014
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Proposed Residual Tumor Classification in Patients With NSCLC After Sleeve Lobectomy.
Chen T; Zhong Y; Wen J; Deng J; She Y; Zhu Y; Chen Q; Wu C; Hou L; Jiang L; Chen C
JTO Clin Res Rep; 2023 Oct; 4(10):100574. PubMed ID: 37822700
[TBL] [Abstract][Full Text] [Related]
4. Validation of the IASLC Residual Tumor Classification in Patients With Stage III-N2 Non-Small Cell Lung Cancer Undergoing Neoadjuvant Chemoradiotherapy Followed By Surgery.
Lee J; Lee J; Hong YS; Lee G; Kang D; Yun J; Jeon YJ; Shin S; Cho JH; Choi YS; Kim J; Zo JI; Shim YM; Guallar E; Cho J; Kim HK
Ann Surg; 2023 Jun; 277(6):e1355-e1363. PubMed ID: 35166266
[TBL] [Abstract][Full Text] [Related]
5. Beyond Margin Status: Population-Based Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification Recategorization.
Osarogiagbon RU; Faris NR; Stevens W; Fehnel C; Houston-Harris C; Ojeabulu P; Akinbobola OA; Lee YS; Ray MA; Smeltzer MP
J Thorac Oncol; 2020 Mar; 15(3):371-382. PubMed ID: 31783180
[TBL] [Abstract][Full Text] [Related]
6. Residual tumor descriptors proposed by the International Association for the Study of Lung Cancer may not be applicable to stage I and ground-glass opacity-featured non-small cell lung cancer.
Wen Z; Fu F; Zhao Y; Gao Z; Han H; Li H; Ye T; Hu H; Sun Y; Li Y; Zhang Y; Chen H
Transl Lung Cancer Res; 2023 Nov; 12(11):2157-2168. PubMed ID: 38090514
[TBL] [Abstract][Full Text] [Related]
7. Prognostic evaluation of the proposed residual tumor classification in a Chinese non-small cell lung cancer population.
Ren Y; She Y; Tang H; Deng J; Jiang G; Wu C; Zhu Y; Zheng H; Chen C
J Surg Oncol; 2022 May; 125(6):1061-1070. PubMed ID: 35099810
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Proposed International Association for the Study of Lung Cancer Residual Tumor Classification to Upgrade Extracapsular Extension of Tumor in Nodes From R0 to Incomplete Resection.
Xie H; Dai C; Gu C; Zhao S; Xu L; Wang F; Gao J; Su H; Wu J; She Y; Ren Y; Wu C; Chen C
J Thorac Oncol; 2024 Jan; 19(1):130-140. PubMed ID: 37567388
[TBL] [Abstract][Full Text] [Related]
9. The addition of radiotherapy to adjuvant chemotherapy has a combinatorial effect in pN2 non-small cell lung cancer only with extranodal invasion or multiple N2 metastasis.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Park SI; Kim DK
Lung Cancer; 2021 May; 155():94-102. PubMed ID: 33765654
[TBL] [Abstract][Full Text] [Related]
10. Comparison between lymph node station- and zone-based classification for the future revision of node descriptors proposed by the International Association for the Study of Lung Cancer in surgically resected patients with non-small-cell lung cancer.
Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
Eur J Cardiothorac Surg; 2019 Nov; 56(5):849-857. PubMed ID: 31168596
[TBL] [Abstract][Full Text] [Related]
11. Validation study of the proposed IASLC staging revisions of the T4 and M non-small cell lung cancer descriptors using data from 23,583 patients in the California Cancer Registry.
Ou SH; Zell JA
J Thorac Oncol; 2008 Mar; 3(3):216-27. PubMed ID: 18317063
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Uncertain Resection for Overall Survival in Non-small Cell Lung Cancer.
Kadomatsu Y; Nakamura S; Ueno H; Goto M; Ozeki N; Fukumoto K; Fukui T; Suzuki Y; Chen-Yoshikawa TF
Ann Thorac Surg; 2022 Oct; 114(4):1262-1268. PubMed ID: 34474024
[TBL] [Abstract][Full Text] [Related]
13. Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery.
Gagliasso M; Migliaretti G; Ardissone F
Lung Cancer; 2017 Sep; 111():124-130. PubMed ID: 28838382
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer.
Yun JK; Bok JS; Lee GD; Kim HR; Kim YH; Kim DK; Park SI; Choi S
Eur J Cardiothorac Surg; 2020 Jul; 58(1):59-69. PubMed ID: 32155245
[TBL] [Abstract][Full Text] [Related]
15. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
Ignatius Ou SH; Zell JA
J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors for Surgically Resected N2 Non-small Cell Lung Cancer.
Kawasaki K; Sato Y; Suzuki Y; Saito H; Nomura Y; Yoshida Y
Ann Thorac Cardiovasc Surg; 2015; 21(3):217-22. PubMed ID: 25641029
[TBL] [Abstract][Full Text] [Related]
17. Recommended Change in the N Descriptor Proposed by the International Association for the Study of Lung Cancer: A Validation Study.
Park BJ; Kim TH; Shin S; Kim HK; Choi YS; Kim J; Zo JI; Shim YM; Cho JH
J Thorac Oncol; 2019 Nov; 14(11):1962-1969. PubMed ID: 31442497
[TBL] [Abstract][Full Text] [Related]
18. The IASLC Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer.
Rusch VW; Crowley J; Giroux DJ; Goldstraw P; Im JG; Tsuboi M; Tsuchiya R; Vansteenkiste J; ; ; ;
J Thorac Oncol; 2007 Jul; 2(7):603-12. PubMed ID: 17607115
[TBL] [Abstract][Full Text] [Related]
19. Recommended changes for T and N descriptors proposed by the International Association for the Study of Lung Cancer - Lung Cancer Staging Project: a validation study from a single-centre experience.
Ruffini E; Filosso PL; Bruna MC; Coni F; Cristofori RC; Mossetti C; Solidoro P; Oliaro A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1037-44. PubMed ID: 19692259
[TBL] [Abstract][Full Text] [Related]
20. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population.
Kassis ES; Vaporciyan AA; Swisher SG; Correa AM; Bekele BN; Erasmus JJ; Hofstetter WL; Komaki R; Mehran RJ; Moran CA; Pisters KM; Rice DC; Walsh GL; Roth JA
J Thorac Cardiovasc Surg; 2009 Aug; 138(2):412-418.e1-2. PubMed ID: 19619787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
